Purpose of the development: It is used to assess the allergy and immunologic characteristics in microbial eczema.

Recommended application field: Medicine, dermatovenereology, infectious diseases, physiatrics.

Advantages over analogues: The majority of patients showed increased sensitivity to various allergens (bacterial, household, medicinal, pollen and epidermal), which is more pronounced in patients with advanced process and dlitelnostyuzabolevaniya 5-10 years. Prevalent polyvalent sensitization. Revealed the importance of the boundary of allergens in the microbial etiology of eczema. Installed depression of cellular immunity manifested decrease in the overall number of T-lymphocytes and T-suppressor subopopulyatsii them. Revealed elevated serum total IgE and circulating immune complexes. Immunological disorders depended on the extent and duration of the dermatosis. The complex method of treatment of microbial eczema increased the effectiveness of treatment by 1.7 times, reduced treatment time by 1.4 times normalized the majority of modified para-clinical indicators.

The development stage readiness: Introduced in production

Description of the development:
()
Most patients with microbial eczema installed polyvalent sensitization, depending on the length of the distribution process. Found suppression of the activity of cellular immunity while enhancing humoral. The high efficiency of the complex treatment of patients with microbial eczema immunostimulant (tsikloferona and timogena). A comprehensive treatment of patients with microbial eczema using immunostimulant tsikloferona widely used in kozhevenerologicheskih institutions. The report considered at the meeting of the Academic Council of the Tajik Institute of postgraduate medical training of the Ministry of Health of the Republic of Tajikistan.

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity

Photo

Country Tajikistan

For additional information turn to:
E-mail: gal@uintei.kiev.ua